Economic modeling can help you determine the economic impact of your product when head-to-head clinical trials are not feasible or available. We have broad experience developing economic models that reflect the variables influencing the economic impact of your product and the logic rules to reflect the relationship between them.
How our Clients Use Our Models
Describe disease and treatment pathways
Burden of illness estimates
Drug and medical resource utilization patterns
Surrogate endpoints linked to long-term outcomes
Support strategic planning
Compound selection for drug development
Clinical trial design (comparators, outcomes)
Positioning evaluation (indications, place in treatment pathway)
Health technology assessment (HTA) submission models
Pricing, reimbursement, and market access (e.g., formulary placement)
Field tools (e.g., cost calculators, interactive models)
Types of Economic Models
We advise our clients on the best type of model given their objectives. Our staff are trained in state-of–the-art modeling methods and have experience with:
We follow a detailed process to build precise, reliable models that account for all relevant variables. Steps include:
Review clinical trial data
Perform a systematic literature review
Gather other available evidence from databases, observational studies and subject matter experts
Develop a conceptual framework for the model
Run validation checks for clinical and structural logic
Quality Control
Run primary and sensitivity analyses and summarize the results
Develop user interfaces and user guides and training materials depending on your needs
Trust Our Experience
We have extensive experience building both simple and complex models. In collaboration with our clients we have frequently presented our models at scientific conferences or published results in peer-reviewed scientific journals. When you collaborate with RTI-HS to develop a model you can be confident in its predictive ability, and application to your product development and commercialization decisions.
